All filters
Slidesets
Model-based TDM for oncology drugs | Ron Keizer, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Physiologically based PK model vs. Population PK approach during drug development | Italo Poggesi, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Opening Lecture: Inter- and intravariability in PK | Mark Ratain, MD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanoma
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Clinical case discussions | Nielka van Erp, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
PK and PKPD considerations for dose selection in the development of pembrolizumab | Dinesh de Alwis, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Clinical Case Discussion 1- Dr. T.R. Constant Vergara
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Is Baseline Resistance Testing Needed?- Ricardo Diaz, MD
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case Discussion 3- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard Elion
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case on Integrase Inhibitors Use in TB-Infected Patients- Dr. L. Grinsztejn
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Basic Science of Integrase Inhibitors - Recent Advances- Francois Clavel, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Pharmacology related considerations- David Back, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Pediatric use of Integrase Inhibitors- Mark Cotton, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana Ramos
Presented at:
Global HIV Clinical Forum 2017
Slidesets
The Role of Integrase Inhibitors during HIV prevention- Pep Coll, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Case -Reduced Drug Regimen- Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2017